Fig. 4. Drug profiles in cinacalcet naïve patients (upper panel) and in patients after a 12 weeks run in phase (lower panel). While the optimal daily administration leads to higher exposure, reliable three times a week administration is not inferior to a daily administration scheme considering a more realistic adherence rate.